Praharshinie Rupasinghe

ORCID

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 8

Top Venues

Microbiology spectrum

Antimicrobial agents and chemotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Praharshinie Rupasinghe, Rabab Reenaers, Jens Vereecken, Wim Mulders, Sari Cogneau, Matthias Merker, Stefan Niemann, Shaheed Vally Omar, Leen Rigouts, Claudio Umberto Köser, Tom Decroo, Bouke C de Jong
Refined understanding of the impact of the Mycobacterium tuberculosis complex diversity on the intrinsic susceptibility to pretomanid. Microbiology spectrum 12 (3) (2024)
Praharshinie Rupasinghe, Azka Ashraf, Nadia Barreda, Shafiqua Parveen, Muhammad Zubair, Roger I Calderon, Sunil Asif, Nilma Hirani, Layila Chingisova, Atang Bulane, Pham Thu Hang, Doan Thu Ha, Elisa Ardizzoni, Nazia Kursheed, Willem Bram De Rijk, Leen Rigouts, Lorenzo Guglielmetti, Carol Mitnick, Bouke C de Jong
Reduced critical concentration might not have improved MGIT-based DST's sensitivity to rifampicin. Antimicrobial agents and chemotherapy 68 (5) (2024)
Praharshinie Rupasinghe, Rabab Reenaers, Jens Vereecken, Wim Mulders, Sari Cogneau, Matthias Merker, Stefan Niemann, Shaheed Vally Omar, Leen Rigouts, Claudio Umberto Köser, Tom Decroo, Bouke C de Jong
Refined understanding of the impact of the Mycobacterium tuberculosis complex diversity on the intrinsic susceptibility to pretomanid. Microbiology spectrum (2024)
Praharshinie Rupasinghe, Rabab Reenaers, Jens Vereecken, Wim Mulders, Sari Cogneau, Matthias Merker, Stefan Niemann, Shaheed Vally Omar, Leen Rigouts, Claudio Umberto Köser, Tom Decroo, Bouke C de Jong
Refined understanding of the impact of the Mycobacterium tuberculosis complex diversity on the intrinsic susceptibility to pretomanid. Microbiology spectrum (2024)
Praharshinie Rupasinghe, Rabab Reenaers, Jens Vereecken, Wim Mulders, Sari Cogneau, Matthias Merker, Stefan Niemann, Shaheed Vally Omar, Leen Rigouts, Claudio Umberto Köser, Tom Decroo, Bouke C de Jong
Refined understanding of the impact of the Mycobacterium tuberculosis complex diversity on the intrinsic susceptibility to pretomanid. Microbiology spectrum 12 (3) (2024)
Praharshinie Rupasinghe, Rabab Reenaers, Jens Vereecken, Wim Mulders, Sari Cogneau, Matthias Merker, Stefan Niemann, Shaheed Vally Omar, Leen Rigouts, Claudio Umberto Köser, Tom Decroo, Bouke C de Jong
Refined understanding of the impact of the Mycobacterium tuberculosis complex diversity on the intrinsic susceptibility to pretomanid. Microbiology spectrum 12 (3) (2024)
Praharshinie Rupasinghe, Azka Ashraf, Nadia Barreda, Shafiqua Parveen, Muhammad Zubair, Roger I Calderon, Sunil Asif, Nilma Hirani, Layila Chingisova, Atang Bulane, Pham Thu Hang, Doan Thu Ha, Elisa Ardizzoni, Nazia Kursheed, Willem Bram De Rijk, Leen Rigouts, Lorenzo Guglielmetti, Carol Mitnick, Bouke C de Jong
Reduced critical concentration might not have improved MGIT-based DST's sensitivity to rifampicin. Antimicrobial agents and chemotherapy 68 (5) (2024)
Praharshinie Rupasinghe, Azka Ashraf, Nadia Barreda, Shafiqua Parveen, Muhammad Zubair, Roger I Calderon, Sunil Asif, Nilma Hirani, Layila Chingisova, Atang Bulane, Pham Thu Hang, Doan Thu Ha, Elisa Ardizzoni, Nazia Kursheed, Willem Bram De Rijk, Leen Rigouts, Lorenzo Guglielmetti, Carol Mitnick, Bouke C de Jong
Reduced critical concentration might not have improved MGIT-based DST's sensitivity to rifampicin. Antimicrobial agents and chemotherapy (2024)

Praharshinie Rupasinghe.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Praharshinie Rupasinghe